Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
DNA and Bankruptcy Collide With 23andMe | Big Take
Posted
April 7, 2025
Views
789
Likes
9
Comments
3
Engagement
1.52%
April 7, 2025
789
9
3
1.52%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
16:31Now PlayingThe genetic testing company 23andMe filed for bankruptcy in March, after years of slowing sales, legal trouble, and a declining stock price. And now, the valuable trove of genetic data the company owns is for sale, sparking privacy concerns.
On today’s Big Take, Bloomberg biotech reporter Gerry Smith traces the rise and fall of 23andMe, and bankruptcy reporter Jonathan Randles outlines what a possible sale could mean for millions of users’ genetic data.
Read moreBankrupt 23andMe’s DNA Data Gets Sale Nod as Concerns Linger ()
The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.
Subscribe to Bloomberg Podcasts
Listen to more of The Big Take
#Bloomberg #Podcast #News #Business #Economy #TheBigTake
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
